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Abstract
The Effects of Cryopreservation on Human Dental Pulp-Derived Mesenchymal Stem Cells

By

Allison Tomlin

Dr. Karl Kingsley, Examination Committee Chair
Associate Professor of Biomedical Sciences
Director of Student Research
University of Nevada, Las Vegas
School of Dental Medicine

Many studies have demonstrated clinical applications for the use of dental pulp stem cells
(DPSC) for the treatment of various conditions. This has driven medical and scientific interest in
the collection, isolation and banking of DPSC tissues for research into these potential therapies.
Few studies to date have evaluated the viability of DPSC following long-term cryopreservation.
The purpose of this study is to evaluate the effects of cryopreservation on dental pulp-derived
stem cells (DPSC) viability over a period of three years. Dental pulp-derived stem cells were
isolated and cultured from thirty-one healthy teeth. DPSC isolates were assessed for doublingtime and baseline viability prior to cryopreservation and were assessed again at three time points;
one week (T1), 18 months (T2), and 36 months (T3). DPSC can be grouped based on their
observed doubling times; slow (sDT), intermediate (iDT), and rapid (rDT). Viability results
demonstrated all three types of DPSC isolates (sDT, iDT and rDT) exhibit time-dependent
reductions in viability following cryopreservation, with the greatest reduction observed among
iii

sDT-DPSCs and the smallest observed among the rDT-DPSC isolates. Cryopreserved DPSCs
demonstrate time-dependent reductions in cellular viability. Although reductions in viability
were smallest at the initial time point (T1) and greatest at the final time point (T3), these changes
were markedly different among DPSC isolates with similar doubling times (DTs). Furthermore,
the analysis of various DPSC biomarkers – including both intracellular and cell surface markers,
revealed differential mRNA expression. More specifically, the relative high expression of Sox-2
was only found only among the rDT isolates, which was associated with the smallest reduction in
viability over time. The expression of Oct4 and NANOG were also higher among rDT isolates,
however, expression was comparatively lower among the sDT isolates that had the highest
reduction in cellular viability over the course of this study. My second study may suggest that
some biomarkers, including Nestin, NANOG, Sox-2, Oct4 may have some potential for use as
biomarkers that may be associated with either higher or lower cellular viability over long-term
storage applications. The analysis of these specific intracellular biomarkers revealed that Oct4
and Sox-2 may be the most important variable factors associated with both DPSC growth rate
and viability during cryopreservation. This information may be useful for future applications and
therapies that could screen and sort DPSC using predetermined biomarkers to improve both
efficiency and feasibility.
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Chapter 1: Introduction
Background and Significance
Many recent studies using animal models have demonstrated clinical applications for the
use of dental pulp stem cells (DPSC) for the treatment of various conditions, including oral and
maxillofacial reparation, retinal disorders, neuropathies and central nervous system disorders
(Aurrekoetxea et al., 2015; Hata et al., 2015; Mead et al., 2016; Nagpal et al., 2016). Human
dental pulp stem cells (DPSCs) have been shown to be very important in the future of
regenerative medicine. New evidence has elucidated several potential mechanisms for inducing
DPSC differentiation prior to implantation or clinical use, including induction into neural,
osteogenic and odontoblastic precursors (Zhang et al., 2016; Liu et al., 2015; Ailan et al., 2015).
These developments have led to considerable scientific interest in DPSC and their potential to
generate novel and innovative treatments for common, as well as intractable, disease states
(Collart-Dutilleul et al., 2015; Chen et al., 2015; Mead et al., 2015). These advances have
driven broad medical and scientific interest in the collection, isolation and banking of DPSC
tissues for research into these potential therapies (Eubanks et al., 2014; Lindemann et al., 2014;
Wu et al., 2015).
Storage and post thaw recovery of DPSCs techniques are very important elements to
study and are key to ensure DPSCs have no loss of function and have potential to differentiate.
Factors and conditions that may influence quantity and quality of the DPSCs include the specific
methods used to isolate, collect, concentrate and store them, temperature stored, and length of
time stored. It was shown that DPSC could be stored at -85 ℃ or -196 ℃ for at least 6 months
without loss of function. Greater than 85% of DPSC were able to be recovered and isolated post-
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thaw and maintained morphological and developmental competence and able to undergo
differentiation (Perry et al., 2008).
Many methods have been described for DPSC cryopreservation, although no definitive
standards have yet been defined for the predicted range of viability over long-term storage and
the effects of differing cryopreservation methods and protocols (Perry et al., 2008; Woods et al.,
2009; Gronthos et al., 2011;Gioventu et al., 2012; Lee et al., 2012). Based upon this paucity of
evidence, the main objective of this study is to evaluate the effects of cryopreservation on DPSC
viability over a period of three years. The current aims of this study are to characterize and
evaluate the effects of long-term cryopreservation, as well as to identify biomarkers that may be
useful for future potential screening and applications. These data, combined with detailed
descriptions of the methods used for isolation, cryopreservation and storage will help to facilitate
larger systematic reviews and meta-analyses for further evaluation of the effects of
cryopreservation on the viability of DPSC during long-term storage.

Research Question
1. How does cryopreservation affect dental pulp stem cell growth? How does cryopreservation
for different time frames affect viability of dental pulp stem cells? Are the survival rates of
dental pulp stem cells changing through different time points?
H0: No, there is no effect on dental stem pulp cell or viability over different time frames (0
months, 18 months, 36 months) of cryopreservation.
HA: Yes; there is an effect on dental stem pulp cell or viability over different time frames (0
months, 18 months, 36 months) of cryopreservation.
2. Are there differences between the different sub-types of dental pulp stem cells (DPSCs)?
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a. What are the phenotypes of DPSC (growth)?
b. What are the biomarkers associated with these phenotypes?
c. What are the differences over various cryopreservation times?
H0: No, there is no difference in DPSC viability based on subtype or biomarker over
different time frames (0 months, 18 months, 36 months) of cryopreservation.
HA: there is a difference in DPSC viability based on subtype or biomarker over different
time frames (0 months, 18 months, 36 months) of cryopreservation.

Approval
The protocol for this study titled “Evaluation of the effects of cryopreservation on
survival of dental pulp stem cells” (OPRS#763012-1) was approved by the University of
Nevada, Las Vegas (UNLV) Biomedical Institutional Review Board (IRB) on August 3, 2015.
The UNLV Office of Research Integrity and Protection of Research Subject (OPRS) originally
approved the protocol for this study titled “Isolation of Non-Embryonic Stem Cells from Dental
Pulp” at the University of Nevada, Las Vegas - School of Dental Medicine (UNLV-SDM;
OPRS#0907-3148) on February 5, 2010. To summarize the original protocol briefly, patients
were recruited at random by UNLV-SDM clinic members (faculty and students), during their
dental visits between February 2010 and February 2011. Informed Consent was required and
was conducted onsite.

Research Design
This research design is retrospective. Dental pulp-derived stem cells were isolated and
cultured from thirty-one healthy teeth. DPSC isolates were assessed for doubling-time and
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baseline viability prior to cryopreservation and will be assessed again at three time points; one
week (T1), 18 months (T2), and 36 months (T3).
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Chapter 2
The Effects of Cryopreservation on Human Dental Pulp-Derived Mesenchymal Stem Cells
This chapter has been published in “Biomaterials and Biomedical Engineering (BME)”, An Int.
Journal, and is presented in the style of that Journal. The complete Citation is:
Tomlin A., Sanders MB, Kingsley K. The effects of cryopreservation on human dental pulpderived mesenchymal stem cells. Biomaterials and Biomedical Engineering. July 2016, 3(2).
Role of Authors:
Dr. Allison Tomlin designed the study, was the primary author, data collector and analyzer, and
graphics generator. Michael Sanders was secondary author and assisted with data analysis and
assisted with graphics generation. Dr. Karl Kingsley was tertiary author and assisted with data
analysis.
Abstract
The purpose of this study is to evaluate the effects of cryopreservation on dental pulpderived stem cells (DPSC) viability over a period of three years. Dental pulp-derived stem cells
were isolated and cultured from thirty-one healthy teeth. DPSC isolates were assessed for
doubling-time and baseline viability prior to cryopreservation and were assessed again at three
time points; one week (T1), 18 months (T2), and 36 months (T3). DPSC can be grouped based
on their observed doubling times; slow (sDT), intermediate (iDT), and rapid (rDT). Viability
results demonstrated all three types of DPSC isolates (sDT, iDT and rDT) exhibit timedependent reductions in viability following cryopreservation, with the greatest reduction
observed among sDT-DPSCs and the smallest observed among the rDT-DPSC isolates.
Cryopreserved DPSCs demonstrate time-dependent reductions in cellular viability. Although
reductions in viability were smallest at the initial time point (T1) and greatest at the final time
point (T3), these changes were markedly different among DPSC isolates with similar doubling
times (DTs). Furthermore, the analysis of various DPSC biomarkers – including both
9

intracellular and cell surface markers, revealed differential mRNA expression.

More

specifically, the relative high expression of Sox-2 was only found only among the rDT isolates,
which was associated with the smallest reduction in viability over time. The expression of Oct4
and NANOG were also higher among rDT isolates, however, expression was comparatively
lower among the sDT isolates that had the highest reduction in cellular viability over the course
of this study. These data may suggest that some biomarkers, including Sox-2, Oct4 and NANOG
may have some potential for use as biomarkers that may be associated with either higher or
lower cellular viability over long-term storage applications although more research will be
needed to confirm these findings.

Key Words: cryopreservation, human dental pulp-derived stem cells effect
Introduction
Applications for the use of dental pulp-derived stem cells (DPSC) have received
considerable attention in recent years (Potdar and Jethmalani, 2015; Conde et al., 2015).
Although DPSCs may have the potential for regeneration of dental and oral tissues, recent
studies have also demonstrated that DPSCs represent a novel class of mesenchymal stem cells
(MSC) that may be capable of differentiation into neurons, cardioac cells, osteoblasts, as well as
liver and even pancreatic cell precursors (Xiao and Nasu, 2014; Ravindran and George, 2015;
Saito et al., 2015). Despite these many advances in cellular and molecular biology and
bioengineering, the potential applications for DPSCs (and ultimately their clinical relevance)
may be predicated upon their regenerative properties that may be dependent upon the methods
used for isolation, characterization, storage and cryopreservation (Huang et al., 2009; Tatullo et
al., 2014).
10

For example, guidelines have recently been issued by the United States regulatory
agency, the American Food and Drug Administration (or FDA), as well as the European
Medicines Agency (AME) for the screening and isolation of DPSC for medical-grade
applications (Ducret et al., 2015). This involved using CD271-, Stro-1, and CD146-positive
DPSCs frozen after P4 for 510 days, which resulted in stable post-thaw doubling times. These
enhanced screening and isolation protocols may facilitate the distinction between subpopulations of DPSC with comparatively different regeneration and clinical applications, such as
those expressing Stro, c-Kit, CD34, and Nestin (Ferro et al., 2014; Pisciotta et al., 2015).
Although these guidelines and recommendations represent significant progress for future clinical
applications, many thousands of DPSCs from clinical patients have already been isolated and
stored in both commercial and academic settings, and little is known about the long-term effects
of cryopreservation and storage for isolates generated prior to these new recommendations
(Zhurova et al., 2010; Lindemann et al., 2014; Kumar et al., 2015).
In fact, many methods have been described for DPSC cryopreservation, although no
definitive standards have yet been defined for the predicted range of viability over long-term
storage and the effects of differing cryopreservation methods and protocols (Perry et al., 2008;
Woods et al., 2009; Gronthos et al., 2011;Gioventu et al., 2012; Lee et al., 2012). Based upon
this paucity of evidence, the main objective of this study to evaluate the effects of
cryopreservation on DPSC viability over a period of three years. These data, combined with
detailed descriptions of the methods used for isolation, cryopreservation and storage will help to
facilitate larger systematic reviews and meta-analyses for further evaluation of the effects of
cryopreservation on the viability of DPSC during long-term storage.
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Methods
Human subjects
The protocol for this study titled “Evaluation of the effects of cryopreservation on
survival of dental pulp stem cells” (OPRS#763012-1) was approved by the University of
Nevada, Las Vegas (UNLV) Biomedical Institutional Review Board (IRB) on August 3, 2015.
The UNLV Office of Research Integrity and Protection of Research Subject (OPRS) originally
approved the protocol for this study titled “Isolation of Non-Embryonic Stem Cells from Dental
Pulp” at the University of Nevada, Las Vegas - School of Dental Medicine (UNLV-SDM;
OPRS#0907-3148) on February 5, 2010. To summarize the original protocol briefly, patients
were recruited at random by UNLV-SDM clinic members (faculty and students), during their
dental visits between February 2010 and February 2011. Informed Consent was required and
was conducted onsite.
Inclusion criteria: subjects had to be between eighteen (18) and sixty-five (65) years old
and must agree to participate. In addition, all potential subjects must have sound, unrestored,
vital teeth (teeth that have healthy pulp tissue), and need to have one or more extractions that are
necessary for oral health, as determined by the clinical faculty member in charge. Exclusion
criteria: Any subject under eighteen (18) or over sixty-five (65) years of age, any subjects having
dental extractions involving compromised pulp or other complications, and any subject that
refuses to donate his or her extracted teeth.

DPSC isolation and culture
In brief, dental pulp was extracted from the vital teeth of healthy adults who agreed to
participate, which were obtained mainly from the orthodontic clinic. The majority of teeth were
12

obtained from the orthodontic clinic, which were extracted due to impaction and/or crowding
(e.g., third molars) or to provide spacing (premolars). The remainder came from the emergency
clinic, which were extracted as a necessity for fabrication of complete dentures. Although most
teeth removed in the emergency clinic are due to injury or due to severe periodontal disease,
these were excluded from participation in this study. The teeth were immediately sectioned
axially at the cemento-enamel junction (CEJ) using a diamond rotary disc in a dental hand piece
and the dental pulp was removed with an endodontic broach.
The dental pulp was then immediately placed into sterile micro centrifuge tubes
containing 1X PBS solution and transferred to the laboratory for culture; any dental pulp not
transferred within two hours was removed from the subsequent analysis. Tubes were preassigned a unique, randomly-generated number to prevent research bias. Demographic
information regarding the sample was concurrently collected, which consisted of patient age,
gender, and ethnicity, as well as tooth type.
Subsequently, the extracted dental pulp was vortexed for 10 – 30 seconds to dislodge
cells and centrifuged for five (5) minutes at 2,100 relative centrifugal force (RCF) or g.
Supernatant (PBS) was aspirated from the tube and dental pulp-derived cells were resuspended
in 1.0 mL of RPMI-1640 medium from Hyclone (Logan, UT) with 2mM L-Glutamine, adjusted
to contain 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 10 mM HEPES, and 1.0 mM sodium
pyruvate. Media was supplemented with 1% Penicillin (10,000 units/mL)-Streptomycin (10,000
mg/mL) solution and 10% fetal bovine serum (FBS), obtained from HyClone (Logan, UT).
Cells were cultured in 75 cm2 BD Falcon tissue-culture treated flasks (Bedford, MA) at 37°C
and 5% CO2 in humidified chambers. Media was changed every 48 hours until adherent cells
reached 70% confluence. Cells were subsequently passaged at a 1:4 ratio.
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Cell survival and viability
Cell confluence was measured with a Zeiss Axiovert 40 inverted microscope (Gottingen,
Germany). During the process of passaging cells, small aliquots of trypsinized cells were stained
using Trypan Blue (Sigma: St. Louis, MO), and live cells were enumerated by counting the
number of Trypan-blue negative cells using a VWR Scientific Counting Chamber or grid
hemacytometer (Plainfield, NJ) and a Zeiss Axiovert 40 inverted microscope (Gottingen,
Germany). During the initial growth phase each potential DPSC isolate reached 70% confluence
or greater between 2 - 12 days. The average doubling time (DT) for the initial ten passages P1P10 of each potential cell line was then established and calculated, revealing average DTs that
varied from 2.5 to 10.25 days. Potential DPSC lines surviving through the tenth passage were
then frozen for storage using a commercially available cryopreservation medium (Opti-Freeze)
from Fisher Scientific (Fair Lawn, NJ), containing Dimethyl Sulfoxide (DMSO), using the
procedure recommended by the manufacturer. For the current study, cell viability was
determined following one week, eighteen months and thirty-six months. DPSC cell lines in
storage at -80°C were thawed, resuspended in the appropriate media, and live cells enumerated,
as described above.

Statistical analysis
The differences between DPSC isolates following cryopreservation (time points) were
measured using a t distribution, a= 0.05. All samples were analyzed using two-tailed t-tests as
departure from normality can make more of a difference in a one-tailed than in a two-tailed t-test
(Hayes, 1994). As long as the sample size is at least moderate (>20) for each group, quite severe
departures from normality make little practical difference in the conclusions reached from these
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analyses. The analyses involving multiple two sample t-tests have a higher probability of Type I
error, leading to false rejection of the null hypothesis, H0. To confirm the effects observed from
these experiments and minimize the possibility of Type I error, further analysis of the data was
facilitated using ANOVA with SPSS (Chicago, IL) to more accurately assess relationships and
statistical significance among and between groups.

RNA isolation
To biomarker mRNA expression from dental pulp stem cells (DPSC), RNA was isolated
7
from 1.5 x 10 cells of each of the experimental cell lines, using ABgene Total RNA Isolation
Reagent (Epsom, Surrey, UK) in accordance with the procedure recommended by the
manufacturer. RNA concentration and purity were calculated using UV spectroscopy. The
absorbance of diluted RNA samples (10 uL of RNA sample in 490 uL nuclease-free water, pH
7.0) was measured at 260 and 280 nm. RNA purity was determined by calculating the ratio of
A260:A280, which should be > 1.80. Concentration for RNA samples was determined by the
A260 reading of 1 = 40 ug/mL RNA, based on an extinction coefficient calculated for RNA in
nuclease-free water. Concentration was calculated as 40 x A260 absorbance measure x dilution
factor (50). Total yield was determined by concentration x sample volume in mL.
Example: RNA standard A260 = 0.75
Concentration = 40 x 0.75 x 50 = 1,500 ug/mL Yield = 1,500 ug/mL x 1.0 mL = 1,500 ug or 1.5
mg RNA
RNA standard: GAPDH
RNA standards obtained from standardized control cells, human gingival fibroblasts
7
isolated from 1.5 x 10 cells were used to establish the minimum threshold (CT) and saturation
15

(CS) cycles required for calibration and concentration comparisons using relative endpoint PCR
(RE- PCR). GAPDH signal detection above background or CT required a minimum of ten cycles
(C10), with saturation or CS observed at C50. Based upon these data, RE-PCR was performed at
C30, above the lower detection limit but below the saturation limit.
GAPDH forward primer, 5’-ATCTTCCAGGAGCGAGATCC-3’; GAPDH reverse primer, 5’ACCACTGACACGTTGGCAGT-3’

Reverse-Transcription Polymerase Chain Reaction (RT-PCR)
To quantify the expression of DPSC-specific mRNA, RT-PCR was performed on total
RNA using the ABgene Reverse-iT One-Step RT-PCR Kit (ReadyMix Version) and a
Mastercycler gradient thermocycler (Eppendorf: Hamburg, Germany) using the following
mesenchymal stem cell (MSC) primers synthesized by SeqWright (Houston, TX):
CD44 forward primer,5’-GAAAGGCATCTTATGGATGTGC-3’ CD44 reverse primer, 5’CTGTAGTGAAACACAACACC-3’
CD133 forward primer, 5’-CTCATGCTTGAGAGATCAGGC-3’ CD133 reverse primer, 5’CGTTGAGGAAGATGTGCACC-3’
NANOG forward primer, 5’-GCTGAGATGCCTCACACGGAG-3’ NANOG reverse primer, 5’TCTGTTTCTTGACTGGGACCTTGTC-3’
Oct4 forward primer, 5’-TGGAGAAGGAGAAGCTGGAGCAAAA-3’ Oct4 reverse primer, 5’GGCAGATGGTCGTTTGGCTGAATA-3’
Sox2 forward primer, 5’-ATGGGCTCTGTGGTCAAGTC-3’ Sox2 reverse primer, 5’CCCTCCCAATTCCCTTGTAT-5’
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Klf4 forward primer, 5’-CGAACTCACACAGGCGAGAA-3’ Klf4 reverse primer, 5’CGGAGCGGGCGAATTT-3’
In brief, one ug of template (total) RNA was used for each reaction. The reverse
transcription step ran for 30 minutes at 47°C, followed by denaturation for 2 minutes at 94°C.
Thirty-five amplification cycles were run, consisting of 20 second denaturation at 94°C, 30
seconds of annealing at 58°C, and 6.5 minutes of extension at 72°C. Final extension was run for
5 minutes at 72°C. Reaction products were separated by gel electrophoresis using Reliant 4%
NuSieve® 3:1 Plus Agarose gels (Lonza: Rockland, ME). Bands were visualized by UV
illumination of ethidium-bromide-stained gels and captured using a Kodak Gel Logic 100
Imaging System and 1D Image Analysis Software (Eastman Kodak: Rochester, NY).
Quantitation of RT-PCR band densitometry and relative mRNA expression levels were
performed using Adobe Photoshop (San Jose, CA) imaging software, Image Analysis tools.
Results
To accurately determine the change in viability DPSC cell cultures were previously
assessed prior to cryopreservation for speed of doubling time (DT) and viability as seen in Figure
1. More specifically, the average doubling time (DT) for the initial five passages was
determined, revealing a characteristic average DT that varied within the range of 2.0 and 10.3
days (Figure 1A). Most DPSC isolates exhibited a very rapid doubling time (rDT, n=27/31) that
ranged between 2.1 and 3.7 days – with a much smaller number of DPSC isolates exhibiting a
much slower doubling time (sDT) of 8 – 10.1 days (n=3/31). Three DPSC isolates, however,
exhibited a temporal decrease in DT observed between passages P6-P10, resulting in an
intermediate doubling time (iDT) of 5.5 – 6.3 days. The baseline viability for these isolates was
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measured prior to cryopreservation and was not significantly different between these three
groups: sDT 94.7%; iDT 97%; rDT 95.7% (p=0.1016).
Viability was measured among these DPSC isolates following cryopreservation at three
subsequent time intervals, after one week (T1), eighteen months (T2) and thirty six months (T3).
These results demonstrated all three types of DPSC isolates (sDT, iDT and rDT) exhibit timedependent reductions in viability following cryopreservation as seen in Figure 1B. More
specifically, the sDT isolates exhibited an average reduction in viability from baseline of -26.7%,
-43.7% and -49% at T1, T2 and T3, respectively. The iDT and rDT isolates also exhibited timedependent reductions in viability from baseline of -6%, -27%, -36.5% (iDT) and -7.1%, -22.9%,
-28.9% (rDT) at T1, T2, and T3 (Table 1).

Figure 1 DPSC doubling time (DT) and viability following cryopreservation. A) Baseline
estimates for proliferation or DT were determined for each of the ten passages (P10) prior to
freezing and cryopreservation. Three basic groups were observed of DPSCs with rapid (rDT),
intermediate (iDT) and slow (sDT) doubling times. B) Following cryopreservation, viability was
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assessed at three subsequent time points; after 1 week (T1), 18 months (T2), and 36 months (T3)
for comparison with baseline estimates.

Table 1 Effects of cryopreservation on DPSC viability over time
T1 (1 week)

T2 (18 months)

T3 (36 months)

sDT

-26.7%

-43.7%

-49.0%

iDT

-6.0%

-27.0%

-36.5%

rDT

-7.1%

-22.9%

-28.9%

This demonstrated an overt difference in viability between the three types of DPSC
isolates, sDT, iDT and sDT, with the greatest reduction observed among sDT-DPSCs and the
smallest observed among the rDT-DPSC isolates. To more accurately assess the time-dependent
trends, average DPSC isolate viability was then determined to evaluate the percent change
between each time point evaluates, such as between T0 and T1 or between T1 and T2 as shown
in Figure 2. These data revealed that the most striking differences between DPSC isolates was
the change in viability between T0 and T1. More specifically, the reduction in viability for sDTDPSCs was -26.7% at T1, but was similar for iDT-DPSCs (-6%,) and rDT-DPSCs (-7.1%).
However, the change in viability measured from T1 to T2 was similar in all three types of DPSC
isolates (-17%, -21%, -15.8%), as was the change from T2 to T3 (-5.3%, -9.5%, -6.4%).
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Figure 2 Analysis of viability change between time intervals following cryopreservation
The observed changes in viability for DPSC isolates with slow (sDT), intermediate (iDT)
and rapid (rDT) doubling times were assessed between each time point (T0-T1, T1-T2, T2-T3),
which revealed large differences in viability between T0 and T1 for sDT-DPSCs, but similar
changes between T1 and T2, as well as T2 and T3 for all DPSC isolates.
In order to elucidate and evaluate these differential observations in cellular phenotype
following cryopreservation, some potential factors that may contribute to these observed changes
in viability over time were analyzed as seen in Figure 3. RNA was successfully isolated from all
of the DPSC isolates prior to cryopreservation, which allowed for the analysis of specific
intracellular biomarkers associated with DPSC in vitro including Klf, Sox2, NANOG, Oct4, as
well as cell surface markers CD44 and CD133 and the housekeeping gene GAPDH (Loveland et
al., 2014; Burnett et al., 2015). The original mRNA analysis was used to plot the relative
intensity of the RT-bands, known as relative endpoint (RE) RT-PCR, which revealed that
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expression was found to be within a narrow range for the majority of the biomarkers evaluated
with some noted exceptions. These included the relatively strong expression of Sox-2 among
rDT DPSC isolates, as well as the differential expression of Oct4 which was also highly
expressed among rDT DPSC but had relatively low expression among sDT. In addition,
NANOG expression was also markedly lower among sDT isolates. No significant differences

Klf4
Sox-‐2

Oct4
NANOG
CD44

Relative	
  mRNA	
  expression	
  

sDT

iDT

rDT

were observed in the expression of cell surface markers or GAPDH.

CD133

rDT

GAPDH

iDT

sDT

Figure 3 Analysis of mRNA expression in DPSC isolates following cryopreservation.

Discussion
The primary goal of this study was to assess the effects of cryopreservation DPSC
viability over time. To further augment this analysis, initial characteristics about these DPSC
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isolates were also evaluated, which included doubling time and baseline viability (Alleman et al.,
2013; Hung et al., 2013). These data, combined with an evaluation of the effects of
cryopreservation on the viability of DPSC during long-term storage following cryopreservation
have revealed time-dependent reductions in cellular viability. Although reductions in viability
were smallest at the initial time point (T1) and greatest at the final time point (T3), these changes
were markedly different among DPSC isolates with similar doubling times (DTs).
For example, the reductions in viability for slowly dividing DPSC isolates (sDT, -26.7%)
were higher than those observed among intermediate (iDT, -6%) or rapid (rDT, -7.1%) DPSC
isolates. These data are similar to observations made in other studies of reductions to DPSC
viability following cryopreservation (Xiao and Nasu, 2014; Pisciotta et al., 2015), however, these
data may also reveal that some functional differences in survival may exist among DPSC isolates
with varying characteristics, such as doubling time. Although these types of effects, such as
reductions in cellular viability over time following cryopreservation, have been observed in other
studies (Lindemann et al., 2014; Kumar et al., 2015) – this may be among the first to describe a
distinguishing phenotype (doubling time) that significantly alters the viability of DPSC isolates
in a more fundamental and straightforward manner.
In addition, although many other studies have described methods for optimizing
cryopreservation of DPSC – these data may be among the first that categorize the viability and
survival potential for DPSC isolates based upon doubling time (Perry et al., 2008; Woods et al.,
2009). Although these data may be limited by the small sample size (n=31), these results may in
fact reveal a more broadly applicable independent variable that can be readily and easily
quantified and which may reveal that optimized methods for cryopreservation may have
fundamentally differing effects on DPSC isolates with varying doubling times.
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Furthermore, the analysis of various DPSC biomarkers – including both intracellular and
cell surface markers, revealed most were not variable among the various isolates (Klf4, CD44,
CD133 and GAPDH) although some differential expression profiles were observed among a
smaller subset. More specifically, the relative high expression of Sox-2 was only found only
among the rDT isolates that was associated with the smallest reduction in viability over time.
Also, the expression of Oct4 and NANOG were also higher among rDT isolates – but more
importantly, were found to be comparatively lower among the sDT isolates that had the highest
reduction in cellular viability over the course of this study. These data may suggest that some
biomarkers, including Sox-2, Oct4 and NANOG may have some potential for use as biomarkers
that may be associated with either higher or lower cellular viability over long-term storage
applications although more research will be needed to confirm these findings.
Conclusions
Future studies will need to explore the biomarkers and other phenotypes of rDT, iDT and
sDT-DPSC isolates to determine if these baseline doubling times underlie differentiation
potential or other cellular characteristics. In addition, future studies should also explore the
various methods, recommendations and guidelines for isolating, characterizing, and storing
DPSCs to determine if these various methods may differentially affect DPSCs with significant
differences in doubling times. These data, when combined with data gleaned from other studies,
provides a more thorough and comprehensive analysis of the effects of cryopreservation on
DPSC isolates and may help to refine the process and ultimately the quality of clinical outcomes
for future studies.
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Abstract
Many studies have demonstrated clinical applications for the use of dental pulp stem cells
(DPSC) for the treatment of various conditions, which have driven medical and scientific interest
in the collection, isolation and banking of DPSC tissues for research into these potential
therapies. Few studies to date have evaluated the viability of DPSC following long-term
cryopreservation. Based upon the paucity of information regarding long-term viability and
biological markers for DPSC, the current aims of this study were to characterize and evaluate the
effects of long-term cryopreservation, as well as to identify biomarkers that may be useful for
future potential screening and applications. Using previously collected DPSC isolates, growth
and viability over a period of four years were examined, revealing an overall decline in viability
at each time point that did not appear to be linear. In addition, the analysis of specific
intracellular biomarkers, including Nestin, NANOG, Sox-2 and Oct4 revealed that Oct4 and
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Sox-2 may be the most important variable factors associated with both DPSC growth rate and
viability during cryopreservation. This information may be useful for future applications and
therapies that could screen and sort DPSC using predetermined biomarkers to improve both
efficiency and feasibility.
Key words: cryopreservation, human dental pulp-derived stem cells, biomarker expression
Introduction
Many recent studies using animal models have demonstrated clinical applications for the
use of dental pulp stem cells (DPSC) for the treatment of various conditions, including oral and
maxillofacial reparation, retinal disorders, neuropathies and central nervous system disorders
(Aurrekoetxea et al., 2015; Hata et al., 2015; Mead et al., 2016; Nagpal et al., 2016). New
evidence has elucidated several potential mechanisms for inducing DPSC differentiation prior to
implantation or clinical use, including induction into neural, osteogenic and odontoblastic
precursors (Zhang et al., 2016; Liu et al., 2015; Ailan et al., 2015). These developments have led
to considerable scientific interest in DPSC and their potential to generate novel and innovative
treatments for common, as well as intractable, disease states (Collart-Dutilleul et al., 2015; Chen
et al., 2015; Mead et al., 2015).
These advances have driven broad medical and scientific interest in the collection,
isolation and banking of DPSC tissues for research into these potential therapies (Eubanks et al.,
2014; Lindemann et al., 2014; Wu et al., 2015). For example, studies from this institution have
demonstrated the feasibility and potential for the collection, isolation and in vitro mechanisms
for culture-induced differentiation and de-differentiation of DPSCs (Alleman et al., 2015;
Loveland et al., 2014; Burnett et al., 2015). However, despite these achievements, much remains
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unknown regarding the parameters, including biological characteristics and biomarkers that
influence not only differentiation, but long-term viability following extended cryopreservation
(Arora et al., 2009; Gioventu et al., 2012; Ma et al., 2012).
Although some prior efforts have evaluated the effects of cryopreservation on DPSC, the
majority of these studies have evaluated only short-term effects (less than six months) (Perry et
al., 2008; Woods et al., 2009; Lindemann et al, 2014; Hata et al., 2015). The few studies that
have investigated the effects of long-term cryopreservation and storage are providing critical
knowledge towards the advancement and ultimate development of DPSC-based therapies (Ma et
al., 2012; Young Kingsley, 2015; Tomlin et al., 2016). Based upon the paucity of information
regarding long-term viability and biological markers for DPSC, the current aims of this study
were to characterize and evaluate the effects of long-term cryopreservation, as well as to identify
biomarkers that may be useful for future potential screening and applications.
Material and Methods
Human Subjects
Original approval for the collection, isolation and storage of dental pulp stem cells
(DPSC) from teeth was granted for protocol OPRS#0907-3148 “Isolation of Non-Embryonic
Stem Cells from Dental Pulp” in February 2010 (Alleman et al., 2013). Approval for the current
study to analyze retrospectively collected biological specimens was granted for protocol
OPRS#763012-1 in August, 2015. In brief, adult patients that were scheduled for an extraction in
the clinic were asked to provide Informed Consent in order to participate. The majority of
patient participants were had one or more healthy, vital intact teeth extracted prior to Orthodontic
treatment (Hung et al., 2013). Patients having teeth extracted due to injury (fracture) or
compromised dental pulp, including pulp infection or disease, were excluded.
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DPSC isolation and culture
The original protocol for the collection and isolation of DPSC from vital, intact teeth
involved isolation of the dental pulp from the pulp chamber following extraction. In brief, this
involved cross sectioning of the tooth at the cemento-enamel junction (CEJ), following by
extraction of the dental pulp with an endodontic broach which was then placed into sterile 1.5
microcentrifuge tubes with phosphate buffered saline (PBS) for transfer to the biomedical
laboratory for culture. The original study protocol allowed for the isolation of dental pulp stem
cells (DPSC) using the direct outgrowth method (Alleman et al., 2013; Bakopoulou et al., 2010).
In brief, cells were allowed to grow for ten passages and the rate of growth or doubling time
(DT) was evaluated and assessed as the interval between 1:4 passaging and achieving
confluence, as previously described (Alleman et al., 2015; Loveland et al., 2014; Burnett et al.,
2015; Tomlin et al., 2016). This allowed for the identification of three distinct classes of DPSC,
those with rapid doubling times (rDT) less than three days, those with relatively slow doubling
times (sDT) of greater than one week (8-10 days), and a smaller subset with intermediate
doubling times (iDT). These phenotypes were noted for each isolate prior to cryopreservation at
(-80C) using OptiFreeze Cryopreservation media from Fisher Scientific (Fair Lawn, NJ), as
previously described (Alleman et al., 2015; Loveland et al., 2014; Burnett et al., 2015, Young
Kingsley, 2015; Tomlin et al., 2016; Hung et al., 2013).

Cell Survival and Viability
Upon thawing at each time point (1 week, 1 month, 6 months, 12 months, 24 months, 36
months and 48 months), viability was assessed using the Trypan Blue exclusion assay as
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previously described (22-24). In brief, thawed cells were centrifuged and resuspended with cell
culture media RPMI-1640 with 2 mM L-Glutamine containing 4.5 g/L glucose, 1.5 g/L sodium
bicarbonate, 10 mM HEPES, 1.0 mM sodium Pyruvate, and 1% Penicillin-Streptomycin (10,000
unit/mL). Aliquots of 20 uL cell suspension were then mixed with Trypan Blue and placed into
hemacytometer counting slides for analysis using a BioRad TC20 automated cell counter
(Hercules, CA) using the protocol recommended by the manufacturer. These data include total
cell number, total live cells (used to calculate viability) and percentage of viable cells. Three
measurements were taken for each DPSC isolate for statistical analysis and averaging.

RNA isolation and RT-PCR
RNA was isolated from an aliquot of each DPSC isolate using 1.0 x 107 cells at each of
the previous time points, including baseline (T0) prior to cryopreservation, and at each of the
subsequent one year time points (T1-T4). RNA was isolated using the total RNA isolation
reagent (TRIR) from Molecular Research Center, Inc. (Cincinnati, OH) using the protocol
recommended by the manufacturer. RNA quality and quantity was assessed using
spectrophotometric analysis of each sample at 260 and 280 nm. The ratio of A260:A280
measurements provides a measurement of RNA purity (acceptable range between 1.7 – 2.0) and
a general estimate of quantity.
All isolates with sufficient quality (A260:A280 > 1.7) and quantity (> 1 ng/uL) were
processed and screened for DPSC biomarker expression as previously described (Alleman et al.,
2015; Loveland et al., 2014; Burnett et al., 2015; Young Kingsley, 2015; Tomlin et al., 2016;
Hung et al., 2013). Mesenchymal stem cell (MSC) and DPSC biomarkers used in this screening
included several previously validated cell surface (CD24, CD44 and CD133) and intracellular
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markers (Nestin, NANOG, Sox-2, Oct4) (Liu et al., 2011, Ferro et al., 2012, Camilleri et al.,
2016), as well as the housekeeping gene GAPDH (glyceraldehyde 3-phosphate dehydrogenase)
or G3PDH, as follows:
CD24 FORWARD: ACTCTCACTTGAAATTGGGC;
CD24 REVERSE: GCACATGTTAATTACTAGTAAAGG;
CD44 forward primer,5’-GAAAGGCATCTTATGGATGTGC-3’
CD44 reverse primer, 5’-CTGTAGTGAAACACAACACC-3’
CD133 forward primer, 5’-CTCATGCTTGAGAGATCAGGC-3’
CD133 reverse primer, 5’-CGTTGAGGAAGATGTGCACC-3’
Nestin FORWARD:

CGTTGGAACAGAGGTTGGAG;

Nestin REVERSE:

TCCTGAAAGCTGAGGGAAG;

NANOG forward primer, 5’-GCTGAGATGCCTCACACGGAG-3’
NANOG reverse primer, 5’-TCTGTTTCTTGACTGGGACCTTGTC-3’
Oct4 forward primer, 5’-TGGAGAAGGAGAAGCTGGAGCAAAA-3’
Oct4 reverse primer, 5’-GGCAGATGGTCGTTTGGCTGAATA-3’
Sox2 forward primer, 5’-ATGGGCTCTGTGGTCAAGTC-3’
Sox2 reverse primer, 5’-CCCTCCCAATTCCCTTGTAT-5’
GAPDH FORWARD: ATCTTCCAGGAGCGAGATCC;
GAPDH REVERSE: ACCACTGACACGTTGGCAGT
In brief, all reactions were standardized using 1 ng/uL of extracted RNA and then
processed using ABgene Reverse-iT One-Step RT-PCR protocol and reagents, as previously
described (Young Kingsley, 2015; Tomlin et al., 2016; Hung et al., 2013). Per standard
procedures, reverse transcript was performed for 30 minutes at 47C and then 30 amplification
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cycles were run, which included denaturation of 20 seconds, annealing of 30 seconds at the
optimal temperature for each primer set, and five minutes of final extension at 72C. Results were
visualized using gel electrophoresis and ethidium bromide in a Kodak Gel Logic 100 Imaging
System and 1D Image Analysis Software (Rochester, NY).

Statistics
Basic descriptive statistics for viability were derived from the viability averages and
reported in tables. DPSC from different categories of growth rates (rDT, iDT, sDT) were
aggregated to create overall averages for these groups. Differences in viability at all time points
between DPSC-rDT, -iDT, and –sDT were evaluated using two-tailed t-tests, which provide
robust analysis even for samples with moderate sizes (n~20) (Jekel et al., 2001; Glaser, 2004).
Results
All DPSC were cultured for a minimum of ten passages to establish their growth rate,
which varied within the range of 2.0 and 10.3 days. The doubling times were then used to group
the DPSC into rapid doubling times (rDT <3 days), intermediate doubling times (4-6 days) or
comparatively slow doubling times (sDT > 8-10 days) – as previously established (Tomlin,
2016). Baseline viability was measured prior to the initial storage and cryopreservation
following the initial ten passages. An aliquot from each DPSC line was retrieved from
cryostorage at each of four time intervals and placed into cell culture (Figure 1). The analysis of
cellular viability at each of the four time points (12 months – 48 months, T1 – T4) revealed an
inverse relationship between the duration of DPSC cryopreservation and cellular viability upon
thawing.
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More specifically, DPSC with a rapid doubling time (rDT) exhibited an average decrease
in cellular viability of -7.1% following 12 months in cryostorage, while DPSC with an
intermediate doubling time (iDT) decreased an average of 6% over this time interval. DPSC
with the slowest doubling time (sDT) exhibited the greatest decrease at this initial time point of 26.7%, which was statistically significant (p<0.01). At each successive time point (T2-T4) all
DPSC isolates exhibited decreasing viability, with the most significant declines observed
between T1 and T2 – while the smallest occurred between T3 and T4.

Figure 1. Effects of cryopreservation on DPSC viability. Initial viability for DPSC isolates with
slow, intermediate and rapid doubling times (sDT, iDT, rDT) was compared with results
following cryostorage after 12 months (T1), 24 months (T2), 36 months (T3) and 48 months
(T4). This revealed overall decreased viability, which varied by DPSC type. DPSC-rDT
exhibited the least reduction in viability (-24%), while DPSC-sDT exhibited the greatest
reduction (-51%) (p<0.01).
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At each time point and determination of cellular viability, mRNA expression was
assessed for multiple specific DPSC biomarkers. Some DPSC biomarkers examined (ABCG,
CD24, CD44, CD133) were not included in this analysis as they exhibited no differences in
mRNA expression (data not shown) (Figure 2). Intracellular mesenchymal stem cell markers
Oct-4, Sox-2, NANOG and Nestin did exhibit differences in mRNA expression and were
examined (Fig. 2A). This analysis revealed differential expression of mRNA among the three
groups DPSC-rDT cell lines. For example, although all three groups were observed to express
mRNA for Nestin and NANOG, only one DPSC-rDT expressed both Sox-2 and Oct4. The
remaining DPSC-rDT exhibited differential expression of either Oct4 or Sox-2 but not both (Fig.
2B). Both of the DPSC-iDT exhibited similar mRNA expression profiles, which included
Nestin, NANOG and Sox-2 but not Oct4. However, all of the DPSC-sDT exhibited similar
expression of Nestin and, to a limited extent, NANOG.

Figure 2. DPSC biomarker expression. A) Total RNA isolated from each DPSC line (rDT, iDT,
sDT) was screened for expression of mRNA specific for DPSC biomarkers Oct4, Sox-2,
NANOG, and Nestin – revealing differential expression among the rDT isolates. Differential
expression was observed between sDT (Sox-2-, Oct4-), iDT (Oct4-) and rDT isolates. B) mRNA
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expression profiles were created using these biomarkers, revealing distinct patterns specific to
sDT and iDT, which may overlap with one of the rDT isolates.
Due to the resulting overlap in the DPSC biomarker expression profiles of the DPSC-iDT
and one of the rDT isolates, viability of each DPSC isolate was further evaluated based upon the
individual expression profile result (Figure 3). Disaggregating the rDT isolates in this analysis
revealed that the rDT isolates expressing Nestin (N), NANOG (N), Sox-2 (S) and Oct4 (O) (NN-S-O) were virtually indistinguishable from the rDT isolates that expressed Nestin, NANOG
and Oct4, but not Sox-2 (N-N-O) (p=0.668). In addition, the overall reduction in viability for the
rDT isolates that expressed Oct4 (regardless of Sox-2) expression was significantly lower than
the reductions in viability among the rDT isolates that expressed Nestin, NANOG, and Sox-2 (NN-S) but not Oct4.
Analysis of viability from the DPSC-rDT and iDT isolates with similar biomarkers
expression profiles of Nestin, NANOG and Sox-2 (N-N-S) revealed similar reductions in
viability at most time points, but were statistically indistinguishable from one another (p=0.241).
Finally, the analysis of DPSC-sDT isolates, which only expressed Nestin and NANOG (N-N)
revealed the greatest reduction in cellular viability at each interim time and the largest reduction
overall between T0 and T4. These findings were significantly different from those of the DPSCiDT and DPSC-rDT isolates evaluated.
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Figure 3. Analysis of cellular viability by DPSC expression profile. Using the biomarker
expression profile, viability for DPSC-rDT isolates with differential expression (N-N-S-O, N-NO, N-N-S) was compared with viability for DPSC-iDT isolates (N-N-S) revealing differential
viability. Both DPSC-rDT isolates expressing Oct4 exhibited similar and smaller reductions in
overall viability (p=0.668), while rDT and iDT with similar profiles exhibited similar, but greater
reductions in viability (p=0.241).

Discussion
This study is among the first to provide evidence that long-term cryopreservation has
significant effects on the viability of DPSC (Tomlin et al., 2016). It is important to note that
although previous studies have evaluated some of the biological effects of cryopreservation on
DPSC, most evaluated these effects after a period of six months or less (Hata et al., 2015;
Lindemann et al., 2014; Woords et al., 2009). If clinical and therapeutic applications are to be a
viable option for patients, more studies regarding the basic biology and feasibility of storage and
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cryopreservation will be needed to further elucidate the parameters that govern these
observations and findings.
More importantly, this study may be the first to provide evidence that the reduced
viability and long-term effects of cryopreservation may not be strictly dose-dependent. For
example, although some studies evaluated and analyzed viability and growth following a short
time interval (usually one to two weeks) compared with a longer time interval (six months) (Hata
et al., 2015; Woods et al., 2009), this study may represent the first evidence to demonstrate that
the declines in viability appear to be most striking within the first two years, with smaller
changes observed in following years and almost no change in viability between years three and
four – regardless of DPSC phenotype (sDT, iDT, rDT). Moreover, the magnitude of these
changes in viability appeared to correlate with cellular phenotype or growth rate – the more
rapidly growing DPSC-rDT exhibiting the smallest reduction in viability at all time points and
the slowest growth DPSC-sDT exhibiting the largest overall reduction.
To more fully examine these observations, the evaluation of biomarkers from each DPSC
isolate revealed similar expression of cell surface markers (CD24, CD44, CD133) but striking
differential expression of key intracellular biomarkers (NANOG, Sox-2, Oct4) (Tomlin et al.,
2016; Liu et al., 2011; Ferro et al., 2012). For example, although all sDT and iDT isolates had
similar expression profiles to one another (N-N and N-N-S, respectively), the three rDT isolates
exhibited differential expression (N-N-S-O, N-N-O, N-N-S). Interestingly, when the viability of
each individual isolate was analyzed independently, this revealed that the rDT and iDT isolates
with similar biomarker profiles (N-N-S) had similar viability following cryopreservation, which
was lower and distinct from the rDT that also expressed Oct4 (N-N-S-O, N-N-O). This may
suggest that Oct4 but not Sox-2, both associated with pluripotency in mesenchymal and dental
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pulp stem cells, may also be associated with (or an indicator of) one or more biological pathways
involved in the regulation of cellular viability (Liu et al., 2011; Ferro et al., 2012).
Despite the significance of these findings, it is important to note that there are several
limitations, which must also be considered. First, this is a retrospective examination of
previously collected DPSC isolates – therefore, the initial conditions of isolation, culture and
storage were outside the parameters of this study and could not be subjected to change or
experimentation. Also, this study was conducted using patients from a public University-based
dental school patient population, which may be significantly different from the traditional
orthodontic patient populations seeking treatment and potential DPSC cryopreservation (Young,
Kingsley 2015). Finally, differing methods or materials for cryopreservation were not studied –
which may have influenced the outcomes observed in this study.
This study is among the first to provide evidence that long-term storage and
cryopreservation of DPSC varies non-linear over time. This study is also among the first to
provide evidence that phenotypic behaviors, such as doubling time or growth, may be one of the
most important factors that determines long-term DPSC viability. Finally, this study also
revealed that Oct4 and Sox-2 are among the most important variable factors that are associated
with both growth and viability, which may be useful for future applications and therapies that
could screen and sort DPSC using predetermined biomarkers.
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Chapter 4: Summary and Conclusions.
The purpose of this project was to assess the effects of cryopreservation on human dental pulpderived mesenchymal stem cells. Chapter 2 of this document investigates DPSC viability after
cryopreservation over the course of three years. Viability and doubling time assessment at multiple time
points revealed the presence of 3 DPSC subtypes with varying time-dependent reductions in viability.
These subtypes (sDT,iDT,rDT) all demonstrated reduction in viability over time, however, the rDT
subtype demonstrated the smallest reduction in viability. The second aim of this project was to

screen and characterize biomarker profiles of these subtypes and determine their correlation with
survival rate. Chapter 3 describes this investigation and found distinct biomarker profiles for the
DPSC isolates. Intracellular mesenchymal stem cell markers Nestin, NANOG, Sox-2, and Oct-4
presented with specific profiles for rDT, iDT, and sDT subtypes. The presence of Oct-4
biomarker was associated with the rDT subtype and greater cell viability. This suggests that Oct4 may also be associated with pluripotency of DPSC and has involvement in the regulation of
cellular viability.
This study is among the first to provide evidence that long-term storage and
cryopreservation of DPSC varies non-linear over time. This study is also among the first to
provide evidence that phenotypic behaviors, such as doubling time or growth, may be one of the
most important factors that determines long-term DPSC viability. Finally, this study also
revealed that Oct4 and Sox-2 are among the most important variable factors that are associated
with both growth and viability, which may be useful for future applications and therapies that
could screen and sort DPSC using predetermined biomarkers. This information may be useful
for future applications and therapies that could screen and sort DPSC using predetermined
biomarkers to improve both efficiency and feasibility of cryopreservation of DPSC.
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Limitations and Recommendations:
One limitation to this project is that it is a retrospective examination of previously
collected DPSC isolates – therefore, the initial conditions of isolation, culture and storage were
outside the parameters of this study and could not be subjected to change or experimentation.
This also limited the number of DPSC samples available in this study. I would recommend
doing a new prospective study with new DPSC isolates to determine DPSC expressed
biomarkers and growth phenotypes first and then predict changes to growth or viability over a
long-term cryopreservation period in order to validate that prediction. Also, this study was
conducted using samples from a public university-based dental school patient population, which
may be significantly different from the traditional orthodontic patient populations seeking
treatment and potential DPSC cryopreservation (Young, Kingsley 2015). It would be better to
have a broader, more diverse sample size.
I would also recommend examining other alternate variables of the DPSC samples such
as gender, age, and tooth type to determine if those variables affect viability and growth of
DPSC. Finally, differing methods or materials for cryopreservation were not studied – which
may have influenced the outcomes observed in this study. Future studies should also explore the
various methods, recommendations and guidelines for isolating, characterizing, and storing
DPSCs to determine if these various methods may differentially affect DPSCs with significant
differences in doubling times and viability.
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